A study by scientists has demonstrated the efficacy of an aminocaproic acid-based medication against radiation exposure.
Timur S. Atchabarov, director of the Kazakhstani Institute of Fundamental and Applied Medicine, told Central Asia Online. According to IA REGNUM, Timur Saliyev, Director of the B. Atchabarov Institute of Fundamental and Applied Medicine of Kazakhstan, a unique development of the scientists may become a panacea against the consequences of radioactive irradiation. According to him, the drug created on the basis of aminocaproic acid will effectively protect the animal organism from radiation.
Experiments on laboratory rats have proved it, he told The First TV Channel. Eurasia. According to him, the rats were given the drug in the form of powder. At the same time, its high digestibility was noted. The rats that received the drug did not feel any effects even after two exposures.
Saliev noted that the drug has a protective function for internal organs, especially the gastrointestinal tract. He recalled that the most dangerous symptom after radiation exposure is damage to the small intestine.
According to the Director of the Research Institute, until now there have been no officially recognized radiation protection drugs in the world. He added that such drugs should give guaranteed protection to the body after radiation exposure. Saliev specified that the Kazakhstani scientists have already received a patent for their discovery.
Photo: from open sources